Beyond the pills: navigating depression and antidepressant use for older adults

CPD
By
AP Staff
-

References 

  1. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Geronto 1986;5(1–2):165–73. 
  2. Australian Institute of Health and Welfare. Mental Health: prevalence and impact of mental illness. 2024. At: www.aihw.gov.au/mental-health/overview/prevalence-and-impact-of-mental-illness  
  3. Australian Institute of Health and Welfare. Mental health prescriptions – mental health. 2024. At: www.aihw.gov.au/mental-health/topic-areas/mental-health-prescriptions  
  4. de Oliveira Costa J, Gillies MB, Schaffer AL, et al. Changes in antidepressant use in Australia: a nationwide analysis (2015–2021). Aust N Z J Psychiatry 2023;57(1):49–57. 
  5. Moncrieff J, Cooper RE, Stockmann T, et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry 2023;28(8):3243–56. 
  6. Blackburn P, Wilkins-Ho M, Wiese B. Depression in older adults: diagnosis and management. BC Med J 2017;59(3):171–7. 
  7. Better Health Channel. Depression and ageing. 2018. At: www.betterhealth.vic.gov.au/health/conditionsandtreatments/depression-and-ageing 
  8. Aziz R, Steffens DC. What are the causes of late-life depression? Psychiatr Clin North Am 2013;36(4):497–516. 
  9. Szymkowicz SM, Gerlach AR, Homiack D, et al. Biological factors influencing depression in later life: role of aging processes and treatment implications. Transl Psychiatry 2023;13(1):160. 
  10. World Health Organisation (WHO). International Statistical Classification of Diseases and Related Health Problems (ICD–11). 2022. At: www.who.int/standards/classifications/classification-of-diseases 
  11. National Institute for Health and Care Excellence (NICE). Depression in adults: treatment and management. 2022. At: www.ncbi.nlm.nih.gov/books/NBK583074/ 
  12. Therapeutic guidelines. 2023. Psychotropic [updated 2021 March]. At: https://tgldcdp.tg.org.au/topicTeaser?guidelinePage=Psychotropic&etgAccess=true 
  13. Castillo S, Begley KJ, Ryan-Haddad A, et al. Depression in the elderly: a pharmacist’s perspective. Formulary 2013;48:388–94. 
  14. Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol 2011;7(6):323–31. 
  15. Allan CE, Valkanova V, Ebmeier KP. Depression in older people is underdiagnosed. Practitioner 2014;258(1771):19-22, 2–3. 
  16. Kok RM, Reynolds CF, 3rd. Management of depression in older adults: a review. JAMA 2017;317(20):2114–22. 
  17. Malhi GS, Bell E, Bassett D, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2021;55(1):7–117. 
  18. Taylor WD. Depression in the Elderly. NEJM 2014;371(13):1228–36. 
  19. Noetel M, Sanders T, Gallardo-Gómez D, et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials. BMJ 2024;384:e075847. 
  20. Firth J, Marx W, Dash S, et al. The effects of dietary improvement on symptoms of depression and anxiety: a meta-analysis of randomized controlled trials. Psychosom Med 2019;81(3):265–80. 
  21. Hvidberg MF. Are antidepressants effective in the treatment of depression in the elderly? A critical umbrella review on reviews, methods, and future perspectives. Mental Health Science 2023;1(2):85–103. 
  22. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018;391(10128):1357–66. 
  23. Jakobsen JC, Gluud C, Kirsch I. Should antidepressants be used for major depressive disorder? BMJ Evid Based Med 2020;25(4):130. 
  24. Rossi S, ed. Australian medicines handbook. 2024. At: https://amhonline.amh.net.au 
  25. Taylor D, Barnes T, Young A. The Maudsley prescribing guidelines in psychiatry. 13th edition. New York: John Wiley & Sons; 2018. 
  26. Kjosavik SR, Gillam MH, Roughead EE. Average duration of treatment with antidepressants among concession card holders in Australia. Aust N Z J Psychiatry 2016;50(12):1180–5. 
  27. Henssler J, Schmidt Y, Schmidt U, et al. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. Lancet Psychiatry 2024;11(7):526–35. 
  28. Keks N, Hope J, Keogh S. Switching and stopping antidepressants. Aust Prescr 2016;39(3):76–83. 
  29. Horowitz M, Taylor D. The Maudsley deprescribing guidelines in psychiatry: antidepressants, benzodiazepines, gabapentinoids and z-drugs. Hoboken, NJ: Wiley-Blackwell; 2024. 
  30. Coupland C, Dhiman P, Morriss R, et al. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551. 
  31. Ou K, Gide DN, El-Den S, et al. Pharmacist-led screening for mental illness: a systematic review. Res Social Adm Pharm 2024;20(9):828–45. 
  32. Moore C, Powell D, Kyle J. The Role of the Community Pharmacist in Mental Health. US Pharmacist 2018;43(11):13–20. 
  33. Gide DN, El-Den S, Lee YLE, et al. Community pharmacists’ acceptability of pharmacist-delivered depression screening for older adults: a qualitative study. Int J Clin Pharm 2023;45(5):1144–52. 
  34. Gide DN, El-Den S, O’Donnell LK, et al. Establishing Mental Health Friendly Pharmacies to Assist in THe Early Identification and Support of OldEr Adults at Risk of Depression: the EMPATHISE pilot study. J American Pharm Assoc 2003. Epub 2024 August 2.